BTMD biote Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: BTMD

Price (delayed)

$2.28

Market cap

$85.69M

P/E Ratio

4.65

Dividend/share

N/A

EPS

$0.49

Enterprise value

$188.79M

?
Relative Growth: Rel. Growth: 17
Relative Strength: Rel. Strength: 29
Relative Valuation: Rel. Valuation: 92
Relative Profitability: Rel. Profitability: 50
Highlights
The equity has grown by 38% YoY and by 4.2% from the previous quarter
biote's quick ratio has plunged by 56% YoY and by 35% from the previous quarter
The EPS has contracted by 43% from the previous quarter and by 28% YoY
Sector: Healthcare
Industry: Medical Care Facilities
Peers: HERE

Key stats

What are the main financial stats of BTMD

BTMD stock price

How has the biote stock price performed over time
Intraday
1.33%
1 week
-6.17%
1 month
8.57%
1 year
-45.19%
YTD
-12.31%
QTD
20.63%

Financial performance

How have biote's revenue and profit performed over time
Revenue
$188.16M
Gross profit
$131.93M
Operating income
$29.03M
Net income
$15.6M
Gross margin
70.1%
Net margin
8.3%
BTMD's net income is down by 42% from the previous quarter and by 26% YoY
BTMD's net margin is down by 41% since the previous quarter and by 22% year-on-year
BTMD's operating income is down by 18% since the previous quarter and by 6% year-on-year
The company's operating margin fell by 17% QoQ

Price vs fundamentals

How does BTMD's price correlate with its fundamentals

Growth

What is biote's growth rate over time

Valuation

What is biote stock price valuation
BTMD P/E details
P/E
4.65
P/B
N/A
P/S
0.37
EV/EBIT
6.16
EV/EBITDA
5.39
EV/Sales
1
The EPS has contracted by 43% from the previous quarter and by 28% YoY
The P/E is 41% more than the last 4 quarters average of 3.3
The equity has grown by 38% YoY and by 4.2% from the previous quarter
The stock's price to sales (P/S) is 38% less than its 5-year quarterly average of 0.6 and 8% less than its last 4 quarters average of 0.4
BTMD's revenue is down by 6% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is biote business performance
The return on assets has declined by 38% since the previous quarter and by 21% year-on-year
BTMD's ROIC is down by 33% since the previous quarter and by 13% year-on-year
The ROS has contracted by 29% from the previous quarter and by 3% YoY

Dividends

What is BTMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BTMD.

Financial health

How did biote financials performed over time
biote's total assets is 35% lower than its total liabilities
biote's quick ratio has plunged by 56% YoY and by 35% from the previous quarter
The company's total liabilities fell by 34% YoY and by 13% QoQ
BTMD's debt to equity has dropped by 58% year-on-year and by 2.7% since the previous quarter
The equity has grown by 38% YoY and by 4.2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.